Ablation study for people with persistent atrial fibrillation
Part of Heart & circulation clinical trials.
This trial tests a catheter ablation procedure for people with persistent atrial fibrillation (a type of irregular heartbeat that lasts more than 7 days but less than a year). It aims to see if the procedure is safe and effective for restoring a normal heart rhythm.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with persistent atrial fibrillation lasting between 7 days and 12 months.
- You are between 18 and 80 years old.
- You are able to attend all study visits for the full length of the trial.
- You have not had any prior heart procedures like ablation, valve surgery, or stent placement.
- You do not have other conditions that could cause your atrial fibrillation, such as thyroid problems or alcohol intoxication.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of ablation (pulsed-field) to treat persistent atrial fibrillation (AFib) that lasts more than 7 days. You may qualify if you have symptoms and haven't had other heart ablation procedures except for one specific type.
This study tests an extra heart ablation procedure for people with persistent atrial fibrillation. It aims to improve the success of the standard treatment by also isolating the back wall of the left atrium, which may help keep your heart rhythm normal longer.
This study tests a new heart procedure using pulsed field ablation (a type of energy to fix irregular heartbeats) for people who have had atrial fibrillation for less than a year. It may help restore a normal heart rhythm and reduce symptoms.
This trial compares two ways to treat persistent atrial fibrillation (an irregular heartbeat that lasts for months or years). One method uses pulsed field energy and the other uses radiofrequency heat to fix the heart's electrical signals. The goal is to see which method is safer and more effective for patients having their first ablation procedure.
This trial is testing a specific approach to catheter ablation for people with persistent atrial fibrillation. It aims to improve how abnormal heart tissue is targeted to help restore a normal rhythm.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
Hear when a new Persistent Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.